Atherosclerotic Heart Disease. Atherosclerotic heart disease
Conditions
Interventions
Intervention 1: First group intervention: receptor of omega-3 fatty acids, 4 g oral cups, twice a day with lunch, for 2 months. Intervention 2: Placebo (oral paraffin) at a dose of 4 g per day for two
Treatment - Drugs
First group intervention: receptor of omega-3 fatty acids, 4 g oral cups, twice a day with lunch, for 2 months
Placebo (oral paraffin) at a dose of 4 g per day for two months
Sponsors
Vice chancellor for research, Tehran University of Medical Sciences
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Cardiac patients, Lack of other diseases,Avoid dietary supplements, vitamins at least 4-6 weeks before and throughout the intervention, No diet, supplements or special activity. Exclusion criteria: A reaction to Omega compounds
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Determination of mean serum NO level before and after intervention in the omega-3 fatty acid supplement group compared to placebo group. Timepoint: 2Month. Method of measurement: Elisa. | — |
Secondary
| Measure | Time frame |
|---|---|
| Body Mass Index (BMI). Timepoint: Before and after 2 months of intervention. Method of measurement: Weight ratio to squared height.;Weight. Timepoint: Before and after 2 months of intervention. Method of measurement: seca scale in kilograms.;Waist. Timepoint: Before and after 2 months of intervention. Method of measurement: Band meters in cm. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahnaz Zarei
Tehran University of Medical Sciences
Outcome results
None listed